AIM ImmunoTech financial statements

에임 이뮤노테크NYSEAMERICAN:AIM · NYSE Amex · Healthcare · sector #17
$0.1825-3.95%
2026-10-06 close

AIM ImmunoTech's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$20M.

Reported results

AIM ImmunoTech notifications

Quantus Signal · live data · not investment advice · Privacy Policy